305 related articles for article (PubMed ID: 23090524)
1. Extending outpatient medical abortion services through 70 days of gestational age.
Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
[TBL] [Abstract][Full Text] [Related]
2. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
4. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
5. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
Winikoff B; Dzuba IG; Creinin MD; Crowden WA; Goldberg AB; Gonzales J; Howe M; Moskowitz J; Prine L; Shannon CS
Obstet Gynecol; 2008 Dec; 112(6):1303-1310. PubMed ID: 19037040
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
7. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
8. The combination of mifepristone and misoprostol for the termination of pregnancy.
;
Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
[TBL] [Abstract][Full Text] [Related]
9. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
10. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
11. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea.
Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS
Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
13. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
14. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
[TBL] [Abstract][Full Text] [Related]
15. Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
Løkeland M; Iversen OE; Engeland A; Økland I; Bjørge L
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):647-53. PubMed ID: 24766569
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
Schaff EA; Fielding SL; Westhoff C
Contraception; 2002 Oct; 66(4):247-50. PubMed ID: 12413620
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
Creinin MD; Schwartz JL; Pymar HC; Fink W
BJOG; 2001 May; 108(5):469-73. PubMed ID: 11368131
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
